Journal Article10.1016/J.IJCARD.2011.06.023
Atrioventricular block 9 days after transcatheter aortic valve implantation
Konstantinos Toutouzas,Archontoula Michelongona,Andreas Synetos,George Latsios,Costas Tsioufis,Christodoulos Stefanadis +5 more
7
About: This article is published in International Journal of Cardiology. The article was published on 18 Aug 2011. The article focuses on the topics: Atrioventricular block.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Genetic Syndromes associated with Congenital Heart Disease.
TL;DR: Common genetic syndromes showing various types of congenital heart disease are introduced, including Down syndrome, Turner syndrome, 22q11 deletion syndrome, Williams syndrome, and Noonan syndrome.
One-year outcomes after direct transcatheter aortic valve implantation with a self-expanding bioprosthesis. A two-center international experience.
Konstantinos Toutouzas,George Latsios,Konstantinos Stathogiannis,Maria Drakopoulou,Andreas Synetos,Elias Sanidas,Antonios Mastrokostopoulos,George Trantalis,Odysseas Kaitozis,George Lazaros,Seyrani Yuecel,Ulrich Gerckens,Eberhard Grube,Dimitrios Tousoulis +13 more
TL;DR: Performing direct TAVI with the self-expanding bioprosthesis is safe and feasible showing similar mortality rates compared to patients undergoing non-direct TAVi at 30 days and at 1 year.
25
Cardio-anesthesiology considerations for the trans-catheter aortic valve implantation (TAVI) procedure
Eleni Melidi,George Latsios,Kostas Toutouzas,Manolis Vavouranakis,Ioannis Tolios,Maria Gouliami,Ulrich Gerckens,Dimitris Tousoulis +7 more
TL;DR: In this article, the authors provide comprehensive insight into the anesthetic management of patients undergoing TAVI and highlight possible gaps in the current knowledge, including the type of anesthesia being used and its possible complications.
23
•Journal Article
Medtronic CoreValve: Achieving Optimal Outcomes.
Konstantinos Stathogiannis,Andreas Synetos,Konstantinos Toutouzas,George Latsios,Antonios Mastrokostopoulos,George Trantalis,Christodoulos Stefanadis,Dimitrios Tousoulis +7 more
TL;DR: One of the available valves, the Medtronic CoreValve system (MCV), which was the first prosthetic valve to be granted the CE mark (May 2007), is focused on in order to take a closer look at its advantages and disadvantages and the ideal conditions that need to be fulfilled for a successful implantation.
6
The First Case of Successful Transcatheter Aortic Valve Implantation Using CoreValve in Korea
In Soo Kim,Young Guk Ko,Sanghoon Shin,Ji-Young Shim,Sak Lee,Byung Chul Chang,Jae Kwang Shim,Young Ran Kwak,Myeong Ki Hong +8 more
TL;DR: An 84-year-old man with symptomatic severe aortic valve stenosis was successfully treated by transfemoral TAVI using a CoreValve in Korea and remained free of adverse clinical event for a follow-up duration of 6 months.
References
Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis.
Hasan Jilaihawi,Derek Chin,Mariuca Vasa-Nicotera,Mohamed Jeilan,Tomasz J. Spyt,G. André Ng,Johan Bence,Elaine Logtens,Jan Kovac +8 more
TL;DR: After transcatheter aortic valve implantation with CoreValve, permanent pacing was performed in around a third of patients and the likelihood of PPM could be predicted with 75% sensitivity and 100% specificity and a receiver operating characteristic curve area of 0.93 +/- 0.055.
231
Early conduction disorders following percutaneous aortic valve replacement.
Valeria Calvi,Euglena Puzzangara,Giusi Paola Pruiti,Sergio Conti,Angelo Di Grazia,Gian Paolo Ussia,Davide Capodanno,Corrado Tamburino +7 more
TL;DR: This work examined the incidence and characteristics of CD in the immediate postoperative period after PAVR, and the need for permanent pacemaker (PPM) implantation.
81
Postoperative permanent pacemaker implantation in patients undergoing trans-catheter aortic valve implantation: what is the incidence and are there any predicting factors?
TL;DR: The current best available evidence suggests that the mean incidence of PPM implantation following TAVI is 14.2% (range 0-34%, median 9.7%), although this appears higher with the CoreValve prosthesis than with the Edwards-Sapien prosthesis.
67
•Journal Article
Transcatheter heart valves for the treatment of aortic stenosis: state-of-the-art.
TL;DR: Only with a close collaboration among different specialists, basic researchers and the industry will the future development of transcatheter aortic implantation techniques be ensured.
17
Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis.
Jan Baan,Ze Yie Yong,Karel T. Koch,José P.S. Henriques,Berto J. Bouma,Marije M. Vis,Riccardo Cocchieri,Jan J. Piek,Bas A.J.M. de Mol +8 more
TL;DR: Preexisting disturbance of cardiac conduction, a narrow left ventricular outflow tract, and the severity of mitral annular calcification predict the need for permanent pacing, whereas the only factor shown to be predictive for new-onset LBBB is the depth of prosthesis implantation.